Studies explore role of STING pathway in bone remodeling, denosumab to reduce fracture risk, autotaxin’s role in fibrosis, SSc
Search results for: vitamin D
2014 ACR/ARHP Annual Meeting: Lupus Nephritis
Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication
2014 ACR/ARHP Annual Meeting: Wellness Ultimate Goal in Rheumatology Patient Care
Physician Leroy Hood, MD, PhD, shares his vision of genomics-driven, proactive, wellness-focused medicine in keynote address
Nurses’ Health Study Continues to Offer Valuable Patient Data
Nurses’ cohort of 38 years provides wealth of patient information, research for rheumatologists
Atypical Fractures Associated with Bisphosphonates
Plus, FX006, odanacatib and other rheumatology drug news, safety updates
Persistent Symptomatic Hypocalcemia Due to Denosumab: A Case Review
Patients with osteoporosis and impaired renal function are at risk
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
Lessons Learned from a Patient with Rheumatoid Arthritis
Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues
New Treatments Needed to Prevent Fractures in Osteoporosis
Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact
2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed
New research clarifies signs of rheumatoid arthritis and systemic lupus erythematosus years in advance and could lead to presymptomatic treatment intervention
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 23
- Next Page »